Drug intelligence / Profile preview

Qifu Yin

Development stage
Preclinical
Lead developer
Zhongwei People's Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Qifu Yin is a traditional Chinese medicine (TCM) herbal decoction first described in the Ming Dynasty text 'Jingyue Quanshu'. It is traditionally indicated for the treatment of 'dementia' (chi dai) caused by deficiency of the heart and spleen or kidney essence. The formula is composed of seven primary botanical ingredients: Panax ginseng, Rehmannia glutinosa, Atractylodes macrocephala, Angelica sinensis, Ziziphus jujuba var. spinosa, Glycyrrhiza uralensis, and Citrus reticulata. Modern clinical research focuses on its application in cognitive disorders, including post-stroke cognitive impairment and Alzheimer's disease. Its mechanism is thought to involve neuroprotection through the reduction of oxidative stress, inhibition of neuroinflammation, and modulation of the cholinergic system.

Other names
Seven-Blessing DecoctionQifuyinQifu Decoction
02

Targets

TLR4 (Toll-like receptor 4)Aβ (Amyloid-beta peptides and aggregates)AcetylcholinesteraseTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Qifu Yin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qifu Yin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call